Liposomes modulate docetaxel-induced lipid oxidization and membrane damage in human hepatoma cells

Journal of Liposome Research

Volumn 19, Issue 2, 2009, Pages 122-130

  Yang, Zhijun ^a   Fong, David W F ^a   Yin, Linlin ^a   Wong, Yuenfan ^a   Huang, Wenhua ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Docetaxel; Hepatoma cell; Liposome; Membrane damage; Oxidization

Indexed keywords

DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIOLEOYLPHOSPHATIDYLCHOLINE; DOCETAXEL; LACTATE DEHYDROGENASE; LIPID; LIPOSOME; MALONALDEHYDE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SUPEROXIDE DISMUTASE; TAXOID;

ARTICLE; ASSAY; CANCER CELL CULTURE; CYTOTOXICITY; ENCAPSULATION; HEPATOMA CELL; HUMAN; HUMAN CELL; IC 50; INCUBATION TIME; LIPID PEROXIDATION; MEMBRANE DAMAGE; PRIORITY JOURNAL; DRUG EFFECTS; HEPG2 CELL LINE; LIVER CELL CARCINOMA; LIVER TUMOR; MEMBRANE; METABOLISM; OXIDATION REDUCTION REACTION;

CARCINOMA, HEPATOCELLULAR; HEP G2 CELLS; HUMANS; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; LIPIDS; LIPOSOMES; LIVER NEOPLASMS; MALONDIALDEHYDE; MEMBRANES; OXIDATION-REDUCTION; SUPEROXIDE DISMUTASE; TAXOIDS;

EID: 70350614425     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100802632649     Document Type: Article

References (14)

1. Carstens MG, de Jong PH, van Nostrum CF, Kemmink J, Verrijk R, de Leede LG, et al. The effect of core composition in biodegradable oligomeric micelles as taxane formulations. Eur J Pharm Biopharm. 2008;68:596-606.
2. Crown J, O'Leary M. The taxanes: an update. Lancet. 2000;355:1176-1178.
3. Du X-Y, Yang H, Wang J. Model foundation of cerebral ischemia and determination of SOD and MDA in brain of mongolian gerbi after cerebral ischemia. Chin J Compar Med. 2006;16:664-667.
4. Fogler WE. Immunologic properties and activities of phospholipids. In: (eds.) Cevc G, Marcel Dekkler, Phospholipids Handbook 1993; (pp 817-832). Marcel Dekker, Inc., New York.
5. Geng CX, Zeng ZC, Wang JY. Docetaxel inhibits SMMC-7721 human hepatocellular carcinoma cells growth and induces apoptosis. World J Gastroenterol. 2003;9:696-700.
6. Guéritte-Voegelein F, Guénard D, Lavelle F, Le Goff MT, Mangatal L, Potier P. Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem. 1991;34:992-998.
7. Hammer LW, Boegehold MA. Functional hyperemia is reduced in skeletal muscle of aged rats. Microcirculation. 2005;12:517-526.
8. He H, Yang X, Shi M, Zeng X, Yang J, Wu L, et al. Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS, and oxidative stress in rats. J Pharm Pharmacol. 2008;60:115-123.
9. Immordino ML, Brusa P, Arpicco S, Stella B, Dosio F, Cattel L. Preparation, characterization, cytotoxicity, and pharmacokinetics of liposomes containing docetaxel. J Contr Rel. 2003;91:417-429.
10. Mayer LD, St Onge G. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques. Anal Biochem. 1995;232:149-157.
11. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth. 1983;65:55-63.
12. van Tellingen O, Beijnen JH, Verweij J, Scherrenburg EJ, Nooijen WJ, Sparreboom A. Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice. Clin Cancer Res. 1999;5:2918-2924.
13. Takada Y, Noguchi T, Okabe T, Kajiyama M. Superoxide dismutase in various tissues from rat carcinoma in the maxillary sinus. Cancer Res. 1982;42:4233-4235.
14. Tug T, Karatas F, Terzi SM, Ozdemir N. Comparison of serum malondialdehyde levels determined by two different methods in patients with COPD: HPLC or TBARS methods. Labmedicine. 2005;36:41-44.